IGC Pharma (IGC)

• Market cap: $29.8M
• 1 day: 0.3%
• 5 days: 13.24%
• 1 month: 5.93%
• 3 months: 0.67%
• 6 months: -24.35%
• Year to date: 3.75%
• 1 year: 12.23%
• 5 years: -81.36%
• 10 years: -24.53%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

Employees: 70